Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
71
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 140 publications
(72 citation statements)
references
References 74 publications
1
71
0
Order By: Relevance
“…Although not much time has passed since the introduction of the first report about computational vaccine design, in the recent years, a lot of progress has been made in this regard. Subsequently, numerous vaccines were developed based on computational approaches that include efficient vaccine against Toxoplasma gondii [31], Rickettsia prowazekii [32], Streptococcus pneumoniae [33], Leishmania infantum [34], Chlamydia pneumoniae [35], Brucella abortus [36], Staphylococcus aureus [15], Escherichia coli [37], Vibrio cholera [38], Human immunodeficiency virus-1 [39], Hepatitis C virus [40] and many others. In many empirical studies, the efficacy of computationally designed vaccines is approved [34,39,41,42].…”
Section: Introductionmentioning
confidence: 99%
“…Although not much time has passed since the introduction of the first report about computational vaccine design, in the recent years, a lot of progress has been made in this regard. Subsequently, numerous vaccines were developed based on computational approaches that include efficient vaccine against Toxoplasma gondii [31], Rickettsia prowazekii [32], Streptococcus pneumoniae [33], Leishmania infantum [34], Chlamydia pneumoniae [35], Brucella abortus [36], Staphylococcus aureus [15], Escherichia coli [37], Vibrio cholera [38], Human immunodeficiency virus-1 [39], Hepatitis C virus [40] and many others. In many empirical studies, the efficacy of computationally designed vaccines is approved [34,39,41,42].…”
Section: Introductionmentioning
confidence: 99%
“…Hence, these vaccines are considered efficient Toth, 2011, 2014). Based on the mentioned merits, many researchers, including our team, have worked extensively on the development of these types of vaccines (Farhadi et al, 2015;Hajighahramani et al, 2017;Mahmoodi et al, 2016;Nezafat et al, 2017;Nezafat et al, 2014;Nezafat et al, 2016;Shahbazi et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…The multi-epitope vaccine was designed by joining adjuvant, T-cell and B-cell epitopes with appropriate linkers as described previously (Nezafat et al 2016;Khatoon, Pandey, and Prajapati 2017).…”
Section: Mapping Of Vaccine Constructmentioning
confidence: 99%